期刊文献+

促红细胞生成素对糖尿病心肌病保护作用的研究进展

Research Progress on Protective Effect of Erythropoietin on Diabetic Cardiomyopathy
下载PDF
导出
摘要 糖尿病心肌病是指发生于糖尿病患者,有心脏结构和功能的改变,而不能用高血压性心脏病、冠心病、心脏瓣膜病及其他心脏病变来解释的一种心肌疾病。目前有许多关于糖尿病心肌病的作用机制及治疗方面的研究。现主要对糖尿病心肌病作用机制及促红细胞生成素对糖尿病心肌病的保护作用做一综述。 Diabetic cardiomyopathy describes diabetes-associated changes in the structure and function of the myocardium that cannot be explained by hypertensive heart disease,coronary atherosclerotic heart disease,valvular heart disease and other cardiac diseases.There were many studies on the mechanisms and treatment of diabetic cardiomyopathy.The mechanisms of diabetic cardiomyopathy and the protective effects of erythropoietin on diabetic cardiomyopathy are reviewed in this paper.
作者 牟娇 张新金 MOU Jiao 1 ,ZHANG Xinjin 2(1.The Fourth Affiliated Hospital of Kunming Medical University,Kunming 650000,Yunnan,China; 2.Department of Cardiology,The Second People s Hospital of Yunnan Province,Kunming 650000,Yunnan,Chin)
出处 《心血管病学进展》 CAS 2018年第5期819-822,共4页 Advances in Cardiovascular Diseases
关键词 糖尿病心肌病 促红细胞生成素 自噬 细胞凋亡 Diabetic cardiomyopathy Erythropoietin Autophagy Apoptosis
  • 相关文献

参考文献4

二级参考文献55

  • 1Vijay Sharma,John H McNeill.Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze[J].World Journal of Cardiology,2011,3(9):281-302. 被引量:8
  • 2Marie-Louise Ward,David J Crossman.Mechanisms underlying the impaired contractility of diabetic cardiomyopathy[J].World Journal of Cardiology,2014,6(7):577-584. 被引量:13
  • 3Pitchai Balakumar,Vishal Arvind Chakkarwar,Manjeet Singh.Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat[J]. Molecular and Cellular Biochemistry . 2009 (1-2)
  • 4Ewa Konduracka,Grazyna Cieslik,Danuta Galicka-Latala,Pawel Rostoff,Artur Pietrucha,Pawel Latacz,Grzegorz Gajos,Maciej T. Malecki,Jadwiga Nessler.Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study[J]. Acta Diabetologica . 2013 (4)
  • 5Takayuki Miki,Satoshi Yuda,Hidemichi Kouzu,Tetsuji Miura.Diabetic cardiomyopathy: pathophysiology and clinical features[J]. Heart Failure Reviews . 2013 (2)
  • 6Ronald M. Witteles,Khun Visith Keu,Andrew Quon,Homa Tavana,Michael B. Fowler.Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy[J]. Journal of Cardiac Failure . 2012 (10)
  • 7Falah Aboukhoudir,Sofiene Rekik.Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach[J]. The International Journal of Cardiovascular Imaging . 2012 (6)
  • 8Peng Zhao,Jie Zhang,Xian-Gang Yin,Preben Maharaj,Sharmain Narraindoo,Lian-Qun Cui,Yuan-Sheng Tang.The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy[J]. Life Sciences . 2012
  • 9Zehra Hashim,Shamshad Zarina.Osmotic stress induced oxidative damage: Possible mechanism of cataract formation in diabetes[J]. Journal of Diabetes and Its Complications . 2012 (4)
  • 10Guoguang Wang,Wei Li,Xiaohua Lu,Pengju Bao,Xue Zhao.Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy[J]. Journal of Diabetes and Its Complications . 2012 (4)

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部